Monday 7th December 2020
|Text too small?|
Further to the announcement by Ryman Healthcare Limited (Ryman) of an offer of up to $100 million (with the ability to accept oversubscriptions of up to an additional $50 million at Ryman’s discretion) of 6 year, secured fixed rate bonds maturing on 18 December 2026, Ryman today announced indicative pricing for the offer.
The indicative issue margin range is 2.00% to 2.20% per annum over the underlying swap rate, subject to a minimum interest rate of 2.50% per annum.
The actual issue margin may be above or below the indicative issue margin range. The issue margin and interest rate will be set following a bookbuild process on 10 December 2020 and will be announced by Ryman via NZX shortly thereafter.
The offer opens today and will close on 10 December 2020 following the bookbuild process, with the bonds expected to be issued on 18 December 2020.
Full details of the bond offer are contained in the Product Disclosure Statement (PDS). The PDS is available through www.rymanhealthcare.co.nz/investors/bonds or by contacting the Joint Lead Managers or your usual financial adviser, and must be obtained by investors before they decide to acquire any bonds.
Ryman has applied for the bonds to be quoted on the NZX Debt Market.
There is no public pool for the bonds, with all of the bonds being reserved for the Joint Lead Managers, NZX participants and other approved financial intermediaries invited to participate in the bookbuild.
See the links below for more details:
No comments yet
Napier Port Holdings Limited (NZX: NPH) 2021 Earnings Guidance Update
Comvita Limited (NZX: CVT) Full Year Guidance Update
Scott Technology Limited (NZX: SCT) Meat Industry Contract Win
PaySauce Limited (NZX: PYS) Quarterly Market Update
NZ Windfarms Limited (NZX: NWF) Agrees a New VVFPA for Q1 2022 to Q3 2022
Harmoney Corp Limited (NZX: HMY) 3Q21 Trading Update
Pacific Edge Limited (NZX: PEB) United Healthcare Issues Positive Coverage Cxbladder
Scott Technology Limited (NZX: SCT) 2021 Half Year Announcement
NZX Limited (NZX: NZX) Appoints Specialist Global Expert to Tech Committee
AFT Pharmaceuticals Limited (NZX: AFT) Secures New Partners in Poland and Greece